Advertisement
News
Subscribe to MDT Magazine News

San Antonio's Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients

February 1, 2011 7:38 am | by Bio-Medicine.Org | Comments

SAN ANTONIO, Feb. 1, 2011 /- Texas Institute of Dermatology, Laser and Cosmetics is now offering Alma Lasers AFT™ treatments to South Texas residents including San Antonio and Boerne area to treat superficial vascular and pigmented irregularities and to improve skin color. "I'm very...

TOPICS:

Access MediQuip Names Prakash Patel Chief Executive Officer

February 1, 2011 7:38 am | by Bio-Medicine.Org | Comments

LAKE MARY, Fla., Feb. 1, 2011 /- Access MediQuip (AMQ), the nation's first and largest provider of surgical implant management solutions, announced the appointment of Prakash Patel, M.D. to chief executive officer. He currently serves as the company's chief operating and chief clinical...

TOPICS:

The 'Me-Covery': Saatchi & Saatchi Wellness and Time Inc.'s Health Brand Reveal Historic Shift in Female Consumer Behavior

February 1, 2011 7:38 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- American women are recovering from the economic crisis by prioritizing their own physical and emotional wellness in choices about their spending and brand selection, according to results from a new national consumer survey conducted by Saatchi & Saatchi...

TOPICS:
Advertisement

Calling All 24/7 Moms! Ester-C - The Better Vitamin C, announces the launch of '24/7 Mom Contest'

February 1, 2011 7:38 am | by Bio-Medicine.Org | Comments

BOHEMIA, N.Y., Feb. 1, 2011 /- Ester-C® is proud to announce the launch of the 24/7 Mom Contest, a contest designed to pay tribute to the unsung heroes in our lives – our moms. Do you know a mom who can juggle the house, the kids, scheduling, work and so much more? Then cast...

TOPICS:

Nordstrom Announces 2011 Black History Month Initiative

February 1, 2011 7:36 am | by Bio-Medicine.Org | Comments

SEATTLE, Feb. 1, 2011 /- Nordstrom, Inc. announced today that it is recognizing Black History Month in 2011 by teaming up with Be The Match® to help raise awareness of the critical need for more African American marrow and umbilical cord blood donors. As part of its "Living Well"...

TOPICS:

ERT to Present at the UBS 21st Annual Global Healthcare Services Conference on February 7, 2011

February 1, 2011 7:34 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, Feb. 1, 2011 /- ERT (Nasdaq: ERES ), announced today that Keith Schneck, the Company's Chief Financial Officer, is scheduled to present at the UBS 21st Annual Global Healthcare Services Conference at 8:00 AM EST on February 7, 2011 in New York City. Interested...

TOPICS:

With Healthcare Reform, Be Careful What You Wish For

February 1, 2011 7:34 am | by Diagnostic Imaging | Comments

For those who want to overturn the law, the real risk is that in the longer term it sets up the likelihood of a single-payer system. In my opinion, by making the fines less than the cost of the insurance, it leaves a way for companies to not insure their employees. So it automatically...

TOPICS:

Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects

February 1, 2011 7:33 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Personalized Medicine - scientific & commercial aspects http://www.reportlinker.com/p0203549/Personalized-Medicine---scientific--commercial-aspects.html Summary The...

TOPICS:
Advertisement

Race gap narrows for some cancers in African-Americans; continues to increase for others

February 1, 2011 6:38 am | by EurekAlert | Comments

(American Cancer Society) While the overall death rate for cancer continues to drop among African-Americans, the group continues to have higher death rates and shorter survival of any racial and ethnic group in the US for most cancers. The findings come from Cancer Facts & Figures...

TOPICS:

Genzyme closes $265M unit sale, plans another divestiture

February 1, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. plans to sell its pharmaceutical intermediates business to an affiliate of the International Chemical Investors Group. Today's news comes as the Cambridge biotech giant completes its $265 million cash sale of its diagnostics business to Sekisui Chemical Co, Ltd., announced...

Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer

February 1, 2011 6:32 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Feb. 1, 2011 /- Soligenix, Inc. (OTC Bulletin Board: SNGX ) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that it has appointed Kevin Horgan, MD, as its Senior Vice President and Chief Medical Officer. Dr. Horgan is a board-certified...

TOPICS:

Quest Diagnostics Announces Pricing in Offering of Common Stock by the Company's Largest Shareholder

February 1, 2011 6:31 am | by Bio-Medicine.Org | Comments

MADISON, N.J., Feb. 1, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ) today announced the pricing of the previously announced secondary public offering of 15,377,600 shares of Quest Diagnostics common stock held by its largest stockholder, SB Holdings Capital Inc., an affiliate of...

TOPICS:

Biogen 4Q profit drops 21 pct as expenses rise

February 1, 2011 5:45 am | by The Associated Press | Comments

The biotechnology company Biogen Idec reported that its fourth-quarter profit tumbled 21 percent, citing on Tuesday restructuring charges and rising expenses that outweighed the sales of key drugs.The performance topped expectations on Wall Street and shares rose 3 percent..The Weston, Mass.,...

Massachusetts Sen. Brown urges medical device tax repeal

February 1, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

As Congressional Republicans ready their assault on President Barack Obama's health care reform law, Bay State Sen. Scott Brown said Monday that he would file legislation to chip away at the bill by repealing the medical device tax that he said will stymie job growth in Massachusetts.

Discovery Labs targets 3Q for Surfaxin FDA filing

February 1, 2011 4:45 am | by The Associated Press | Comments

Discovery Laboratories Inc. said Tuesday it aims to file early in the third quarter a complete response to the Food and Drug Administration for its drug Surfaxin.Surfaxin aims to prevent respiratory distress syndrome in premature infants. The Warrington, Pa., company said it believes a key...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading